Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (&gt;4.0 ng/mL)

Lu, Chin Heng; Lin, Tzu Ping; Shen, She Huei; Huang, Yi; Chung, Hsiao Jen; Kuo, Junne Yih; Huang, William J.S.; Wu, Howard H.H.; Chang, Yen; Lin, Alex Tong‐Long; Chen, Kuang Kuo

doi:10.1016/j.jcma.2016.07.007

Cited by 3 publications

(1 citation statement)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prostate biopsy is the most reliable diagnostic procedure for prostate cancer diagnosis[ 1 ]. Ultrasound-guided transrectal prostate biopsy is a commonly used diagnostic method in urology[ 2 ]. In general, procedure-related trauma is minimal; however, other complications may occur, including massive rectal bleeding and systemic infection after the puncture.…”

Section: Introductionmentioning

confidence: 99%

Application of prostate resectoscope in the treatment of massive rectal bleeding after transrectal prostate puncture

Li,

Yang,

et al. 2024

World J Clin Cases

View full text Add to dashboard Cite

BACKGROUND Ultrasound-guided prostate biopsy is a reliable diagnostic procedure for prostate cancer diagnosis with minimal procedure-related trauma. However, complications, such as massive rectal bleeding may occur after the puncture. We hypothesized that using a transrectal resectoscope could help treat massive rectal bleeding after transrectal prostate punctures. AIM To identify a simple and effective treatment for massive rectal bleeding after transrectal prostate punctures. METHODS Patients requiring treatment for massive rectal bleeding after transrectal prostate punctures were included. A SIMAI resectoscope was inserted through the anus. Direct electrocoagulation was performed for superficial bleeding points. Part of the rectal mucosa or surface muscle layer was removed to expose deep bleeding points, followed by electrocoagulation. An electric cutting ring was used to compress and stop the bleeding for jet-like points before electrocoagulation. The fluid color in the drainage tube was monitored postoperatively for continuous bleeding. RESULTS Eight patients were included from 2012 to 2022. None of the patients with massive rectal bleeding after the transrectal prostate punctures improved with conventional conservative and blood transfusion treatments. Two patients had an inferior artery embolism, and digital subtraction angiography was ineffective. All patients received emergency transanal prostate resection, which immediately stopped the bleeding. Four days after the procedure, the patients had recovered and were discharged. CONCLUSION Using a transanal prostate resection instrument is a simple, safe, and effective method for treating massive rectal bleeding after transrectal prostate punctures.

show abstract

Section: Introductionmentioning

confidence: 99%

Application of prostate resectoscope in the treatment of massive rectal bleeding after transrectal prostate puncture

Li,

Yang,

et al. 2024

World J Clin Cases

View full text Add to dashboard Cite

show abstract

Tumor markers and mature cystic teratoma of the ovary

Lee

Horng

Wang

2018

Journal of the Chinese Medical Association

View full text Add to dashboard Cite

Can lower urinary tract symptoms predict pathology outcome in patients with a PSA level of 4-10 ng/mL?

Başer

Aydın

Çelikörs

et al. 2020

Ankara Eğitim Ve Araştırma Hastanesi Tıp Dergisi

View full text Add to dashboard Cite

Bu çalışmada PSA seviyesi 4-10 ng/mL olan hastalarda alt üriner sistem semptomalarının prostat adenokanser ve benign prostat hiperplazisini ön görecek bir parametre olup olmadığını araştırmayı amaçladık. GEREÇ VE YÖNTEMLER: 01 Haziran 2019-01 Şubat 2020 tarihleri arasında PSA değeri 4-10 ng/ml olan ilk kez TRUS-Bx uygulanan 75 hasta prospektif olarak çalışmaya dahil edildi. Hastaların yaş, vücut kitle indeksi, PSA, Prostat hacmi, PSA dansitesi, uluslararası prostat semptom skorları ve uluslararası erektil fonksiyon skorları kayıt edildi. Patoloji sonucuna göre grup 1 (benign prostat hiperplazisi) ve grup 2 (prostat adenokanser) olarak hastalar 2 gruba ayrılarak belirtilen parametreler ile ilişkisi araştırıldı. BULGULAR: PSA değeri 4-10 ng/ml olan ilk kez TRUS-Bx uygulanan 75 hastanın patoloji sonucunda; 57 (%76) hastada benign prostat hiperplazisi (Grup 1), 18 (%24) hastada prostat adenokanser (Grup 2) saptandı. İncelenen parametrelerden sadece parmakle rektal muayenede pozitiflik (sertlik) bulgusu ve IPSS skor düşüklüğü Grup 2' de, Grup 1' e göre istatistiksel anlamlı farklılık saptandı (sırası ile; p=0.001 ve p=0.022). Yapılan korelasyon analizi ile de bulgular teyit edildi. SONUÇ: PSA 4-10 ng/mL olan hastalar için IPSS skor düşüklüğü, parmakla rektal muayenede pozitiflik (sertlik) olması kanser saptanma ihtimalini arttırmaktadır.

show abstract

Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (>4.0 ng/mL)

Cited by 3 publications

References 33 publications

Application of prostate resectoscope in the treatment of massive rectal bleeding after transrectal prostate puncture

Application of prostate resectoscope in the treatment of massive rectal bleeding after transrectal prostate puncture

Tumor markers and mature cystic teratoma of the ovary

Can lower urinary tract symptoms predict pathology outcome in patients with a PSA level of 4-10 ng/mL?

Contact Info

Product

Resources

About